Docking, synthesis, and cytotoxicity of n-(phenylcarbamothioyl)-benzamide on T47D cells.

| Posted in: Health Sciences Science Journals

Journal name: World Journal of Pharmaceutical Research
Original article title: Docking, synthesis and cytotoxic test on human breast cancer cell line t47d of n- (phenylcarbamothioyl)-benzamide
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.

Original source:

This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.

Author:

Dini Kesuma, Siswandono, Bambang Tri Purwanto and Marcellino Rudyanto


Download the PDF file of the original publication


World Journal of Pharmaceutical Research:

(An ISO 9001:2015 Certified International Journal)

Full text available for: Docking, synthesis and cytotoxic test on human breast cancer cell line t47d of n- (phenylcarbamothioyl)-benzamide

Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research

Doi: 10.20959/wjpr20187-11474

Copyright (license): WJPR: All rights reserved


Summary of article contents:

Introduction

Breast cancer is a significant health issue globally, being one of the leading causes of mortality in both developing countries and worldwide. In Indonesia, breast cancer has become the most common cancer diagnosis, overshadowing other types like cervical cancer. This study focuses on the synthesis, docking, and cytotoxic testing of a new compound, N-(phenylcarbamothioyl)-benzamide, as a potential anticancer agent against the T47D human breast cancer cell line. The research addresses the efficacy of this compound in comparison to the reference drug hydroxyurea, with an aim to develop more potent treatments for breast cancer.

Synthesis and Characterization of the Compound

The new compound, N-(phenylcarbamothioyl)-benzamide, was synthesized using the reaction between benzoyl chloride and N-phenylthiourea. The synthesis process involved acyl nucleophilic substitution reactions, followed by purification through recrystallization. The molecular structure of the resultant compound was confirmed using various analytical techniques, including FTIR, 1H-NMR, 13C-NMR, and high-resolution mass spectrometry (HRMS). This thorough characterization ensured the identification of the compound's structural components, laying the groundwork for further testing.

Molecular Docking and In Silico Analysis

The study employed molecular modeling techniques to predict the anticancer activity of the synthesized compound through docking studies with the SIRT1 receptor (PDB code: 4I5I). The results indicated that the N-(phenylcarbamothioyl)-benzamide exhibited a significantly lower Rerank Score (RS) of -119.4130 compared to hydroxyurea's RS of -40.0237, suggesting a more stable interaction with the receptor. This stability is indicative of the compound’s potential effectiveness in targeting cancer cells. In silico findings align with the hypothesis that enhanced bonding with the SIRT1 receptor correlates with increased anticancer activity.

Cytotoxic Testing and Comparison with Hydroxyurea

Cytotoxicity assays were conducted using MTT assays on both T47D cancer cells and normal Vero cells to evaluate the anticancer effects of the new compound. The IC50 value for N-(phenylcarbamothioyl)-benzamide was calculated to be 0.53 mM for T47D cells, showcasing its potency in inhibiting cancer cell viability, significantly outperforming hydroxyurea, which had an IC50 of 4.58 mM. Notably, the compound demonstrated minimal toxicity towards normal Vero cells, with cell death remaining below 15%, indicating a targeted mechanism of action that spares healthy tissue while effectively targeting tumor cells.

Conclusion

In conclusion, the synthesized N-(phenylcarbamothioyl)-benzamide shows promising in vitro anticancer activity against T47D breast cancer cells, surpassing the effectiveness of hydroxyurea. The findings suggest that this compound's binding affinity to the SIRT1 receptor may facilitate its potent anticancer effects. The observed selective toxicity towards cancer cells, alongside low toxicity in normal cells, positions N-(phenylcarbamothioyl)-benzamide as a potential candidate for future development as an anticancer drug. Further investigation is warranted to elucidate the molecular mechanisms underlying this compound’s anticancer activity, which may contribute to advancements in breast cancer treatment.

FAQ section (important questions/answers):

What is the main focus of the study conducted by Kesuma et al.?

The study focuses on synthesizing and testing a new anticancer compound, N-(phenylcarbamothioyl)-benzamide, for its cytotoxic effects on human breast cancer cells (T47D) compared to Hydroxyurea.

How was the compound N-(phenylcarbamothioyl)-benzamide synthesized?

The compound was synthesized by reacting N-phenylthiourea with benzoyl chloride using acyl nucleophilic substitution reactions, followed by characterization using various spectroscopic methods.

What were the IC50 values of N-(phenylcarbamothioyl)-benzamide and Hydroxyurea?

The IC50 value of N-(phenylcarbamothioyl)-benzamide was 0.53 mM for T47D cells, significantly lower than Hydroxyurea's IC50 value of 4.58 mM.

What methods were used to test the anticancer activity?

The anticancer activity was tested in vitro using the MTT assay on T47D cancer cells and normal Vero cells to determine cell viability.

What is the predicted mechanism of action for the new compound?

The new compound is expected to target cancer cells, exhibiting toxicity to them while showing minimal effects on normal cells, based on the IC50 results.

Who contributed to the study and guidance for the docking program?

Professor Mr. Siswandono provided guidance to the authors in utilizing the docking program for molecular modeling and predicting the activity of the synthesized compound.

Glossary definitions and references:

Scientific and Ayurvedic Glossary list for “Docking, synthesis, and cytotoxicity of n-(phenylcarbamothioyl)-benzamide on T47D cells.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.

1) Activity:
Activity refers to the capability of a substance to produce a specific effect, particularly in pharmacology where it indicates how effectively a drug can elicit a desired biological response. In this study, 'activity' often pertains to the anticancer efficacy of the synthesized compound against breast cancer cells, as assessed through experiments such as the MTT assay.

2) Cancer:
Cancer is a disease characterized by the uncontrolled growth of abnormal cells in the body, leading to tumors and potential spread to other tissues. The significance of cancer in this research highlights the focus on developing new anticancer agents, as breast cancer is a prevalent and critical health concern requiring effective treatments.

3) Table:
A table in scientific research is a systematic arrangement of data and results, often presented in rows and columns for clarity. In this paper, various tables display critical experimental outcomes like IC50 values, cytotoxic effects on different cell lines, and docking scores, facilitating easier comparison and analysis of the findings.

4) Drug:
Drugs, in the plural form, encompass a variety of chemical compounds used in medicine, either synthetically or naturally derived. This research contributes to the broader category of drugs by focusing on new anticancer agents derived from thiourea, emphasizing the need for novel drugs that have improved efficacy and specificity.

5) Line:
In the context of cell biology, 'line' refers to a cell line, a population of cells derived from a specific type of tissue and maintained in culture for research purposes. The T47D cell line is utilized in this study to investigate the cytotoxic effects of the synthesized compounds on human breast cancer cells.

6) Study (Studying):
Study denotes a structured investigation undertaken to gain knowledge about a particular subject. This research paper describes a comprehensive study on the synthesis, docking, and cytotoxic evaluation of a new compound, aimed at exploring its potential as a novel anticancer agent against breast cancer cells.

7) Death:
Death refers to the cessation of life, a critical endpoint often associated with severe diseases like cancer. The paper underscores the importance of cancer research given its high mortality rates, particularly breast cancer, advocating for the development of new treatments that could significantly reduce cancer-related deaths.

8) Water:
Water is a crucial solvent in biological systems and laboratory settings. In this study, the term appears in the context of the solubility and physical properties of the synthesized compound. The inability of the compound to dissolve in water signifies its hydrophobic nature, impacting its bioavailability and interaction with biological systems.

9) Discussion:
Discussion refers to the section in a scientific paper where research findings are interpreted, analyzed, and contextualized within the broader field. It evaluates the implications of results, covers limitations, and suggests future work, demonstrating the study's contribution to the ongoing cancer research narrative and potential therapeutic implications.

10) Developing:
Developing pertains to the process of creating or evolving new substances or methodologies. In this context, it relates to the ongoing efforts to develop new anticancer drugs from thiourea derivatives, indicating a proactive stance toward addressing treatment challenges in effectively combating breast cancer.

11) Substance:
A substance is a form of matter that has consistent physical properties. In scientific research, it often refers to chemical compounds being studied. Here, it describes the synthesized compound, emphasizing its role in the experiment as a potential agent for combatting cancer and evaluating its efficacy through various assays.

12) Disease:
Disease refers to an abnormal condition affecting an organism that impairs its normal functioning. Cancer is a notable disease examined in this research, with the aim of finding new therapeutic agents. Understanding the disease's mechanisms and potential treatment options is crucial for advancing medical science and improving patient outcomes.

13) Nature:
Nature signifies the inherent characteristics and properties of substances, creatures, and phenomena. In a research context, it may pertain to the chemical and biological interactions of the compounds being studied, reflecting on how molecular structure influences the bioactivity of the new anticancer agent against breast cancer.

14) Medium:
Medium indicates a substance in which biological processes occur, particularly in cell culture. In the context of this study, it refers to the growth medium used for culturing T47D cancer cells, essential for conducting cytotoxicity assays and evaluating the effectiveness of the tested compounds in a controlled environment.

15) Liquor:
Liquor, in a laboratory context, generally refers to a liquid solution used in various chemical reactions or as a solvent. Here, it is associated with the preparation of test compounds, highlighting the importance of controlling chemical environments during synthesis and testing for desired outcomes in drug efficacy.

16) Filling (Filled):
Filled refers to the action of completing a space or volume with a substance. In scientific experiments, it often describes populating experimental wells with solutions containing cells or compounds. The term is relevant to the procedures of the study where cell cultures are 'filled' with various concentrations of test compounds for evaluation.

17) Arrow:
Arrow is a graphical element used to represent direction or movement in illustrations and diagrams. In this research, arrows indicate interactions or binding sites in molecular docking studies, aiding in visualizing the relationships between synthesized compounds and their target receptors, thus clarifying the binding interactions during drug evaluation.

18) Pur:
Poor denotes suboptimal conditions or results. In the context of drug development, it often describes compounds with insufficient efficacy or bioavailability. The research indicates the limitations of existing therapies, such as hydroxyurea, highlighting the need for better alternatives that overcome the poor performance in cancer treatment regimens.

Other Science Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Docking, synthesis, and cytotoxicity of n-(phenylcarbamothioyl)-benzamide on T47D cells.’. Further sources in the context of Science might help you critically compare this page with similair documents:

Breast cancer, Research study, In vitro, Anticancer activity, Molecular docking, Cytotoxic activity, Chemical structure, FTIR, 1 H NMR, IC 50, Molecular mechanism, Mass spectra, Molecular modeling, 13 C NMR, In Silico, Hydrogen bond, Hydroxyurea, Vero cell.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: